Technology | Vascular Access | August 10, 2016

Access Scientific Debuts PowerWand XL Midline Catheter

Catheter designed specifically for component-based, over-wire insertion technique similar to MST

Access Scientific, PowerWand XL midline catheter

August 10, 2016 — Access Scientific introduced the PowerWand XL, a companion to the PowerWand All-in-One, in July. The Powerwand XL is designed specifically for clinicians who prefer to use a component-based, over-wire insertion technique similar to the Modified Seldinger Technique (MST) they currently use.

The XL technique feels similar to the MST, but XL advantages include:

  • Improves clinical outcomes through atraumatic catheter insertion;
  • Designed to reduce risk of deep-vein thrombosis by up to 500 percent. No trimming of catheter necessary;
  • Reduces risk of back leaking. No peel-away sheath;
  • Guidewire extends fully so the catheter does not drag across the intima of the vessel; and
  • Faster and safer because of fewer steps.

As with MST insertions, the XL insertion technique utilizes a 21-gauge safety needle and guidewire to access the vessel. The XL accelerates line placement and makes it safer compared to MST, according to Access Scientific, by eliminating the need for a peelable introducer sheath. Instead, the proprietary PowerWand XL dilator and catheter are inserted directly over the wire and into the bloodstream. This technique eliminates the sheath-related steps in MST that can be associated with such risks as bleeding, back-leaking and vessel damage.

The All-in-One is inserted with the Accelerated Seldinger Technique (AST), which also improves on the MST in speed, number of steps and safety.

Other attributes of the PowerWand XL include:

  • Size: 4Fr and 5Fr;
  • Length: 8 and 10cm;
  • Infection Prevention: Zero BSIs over 12,000 catheter-days;
  • High Flow: Capable of delivering large volumes rapidly, 130-180 ml/min;
  • Power Injectable: 325psi / 8ml per second;
  • Blood Drawable: Allows for blood draws in most patients, 60 – 99 percent; and
  • Patient Satisfaction: Provides patients with one-stick hospitalization.

For more information:

Related Content

Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.